04/09/2023 1

Business Policy & Strategy Management

Presented By:Rahul Pawar 012003Philomen Prem 012010Sanjeev Kumar 012015Mayur Gupta 012018Jayesh Raut 012023Swapnil Rathore 012025Abhishek Ayarkar 012031Pawan Sharma 012035Khandu Chaudhari 012040

Submitted to : VISHAL SIR

04/09/2023 2

Companies and Products:

Arflur-D-Gel

Arflur-D-Gel

04/09/2023 3

Freedom of choice- Wide spectrum of Therapeutic segments to choose from.

Dedication to serve- Highest quality standards with latest technology at affordable prices.

Care for all- Always committed towards better healthcare solutions.

Mission:FDC is a people oriented organization dedicated to innovate, manufacture and market high-quality healthcare products that enhance the quality of human life all over the globe, and in turn, increase shareholder's value.

Vision:

Expanding Health Horizons...

04/09/2023 4

OBJECTIVERedefining essence of purity, efficacy and convenience through innovation

Core Values:1. Synergy 2. Trust3. Competitiveness4. Openness

5. Integrity6. Discipline7. Creativity8. Quest for excellence

04/09/2023 5

FDC LtdArflur-D-Gel

Category - Analgesic Gel (pain killer gel)Price- 46/30gm₹Competitors: - Volini & Volitra Gel from Ranbaxy, Omini Gel from Cipla

04/09/2023 6

Vision:Enriching lives globally, with quality and affordable pharmaceuticals

Mission: - Achieving customer satisfaction is fundamental to our business.

- Provide products and services of the higher quality.

- Ensure profitable growth and enhance wealth of shareholders.

- Manage our operation with high concern for safety and environment.

- Be a responsible corporate citizen.

Objective:At Ranbaxy, we make good health affordable and accessible to the local communities and society at large.

04/09/2023 7

Business Level Strategies:

FDC: RANBAXY:

ProductDifferentiatio

n

Cost Focus:

Target Customers

Arflur-D-Gel

Cost Leadership

Flexibility

Broad Targe

t

04/09/2023 8

Corporate Level Strategy:

FDC : • Ranbaxy:

Operational Strategy

EXTEND

Business Closure

Extend Expand Enhance

CONCLUSION:

04/09/2023 9

Comparison both the companies with its Drugs using Porter's 5 Forces:

Conclusion:

04/09/2023 10

Comparison both the companies with its Drugs using Generic Value Chain:

InfrastructureHR Management

TechnologyProcurement

Inboud Logistics Operations Outbound Logistics

Marketing and Sales Service

04/09/2023 11

Retrenchment:

• Arflur-D-Gel• Launched 3yrs Back• Less Growth• Less Awareness

• Volini-Gel• Launched 10yrs Back• High Growth Rate• Everyone Knows

04/09/2023 12

Integration:

FDC Limited:• With a modest beginning in 1936 -

marketing vitamins and a range of

prescription formulations - FDC set up its

first formulations manufacturing facility in

1949.

• This shows that FDC follows Backward

Integration.

Ranbaxy:

It started as a Distributor in 1937.

In 1951, Ranbaxy started manufacturing with Italian Company Lepitit.

It shows its backward Integration.

13

BCG Matrix

Arflur-D-Gel??

Cash Cow Dog

High

Low

HighLow

BUSINESS GROWTH

RATE

Market Share

Star Product

04/09/2023 14

Conclusion:

• Though Ranbaxy and F.D.C both are MNC still the companies have there own strategies.

• As discussed all models proves that Ranbaxy stands far better than FDC with its product Volini.

04/09/2023 15